diazooxonorleucine and Sarcoma

diazooxonorleucine has been researched along with Sarcoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertino, JR; Gritsman, H; Li, WW; Tong, WP; Waltham, MC1
Amato, DJ; Borden, EC; Chang, AY; Comis, RL; Davis, TE; Dowd, ME; Earhart, RH; Shiraki, M; Smith, TJ1

Trials

1 trial(s) available for diazooxonorleucine and Sarcoma

ArticleYear
Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas.
    Investigational new drugs, 1990, Volume: 8, Issue:1

    Topics: Aclarubicin; Azo Compounds; Bone Neoplasms; Diazooxonorleucine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Male; Mesothelioma; Middle Aged; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms

1990

Other Studies

1 other study(ies) available for diazooxonorleucine and Sarcoma

ArticleYear
gamma-Glutamyl hydrolase from human sarcoma HT-1080 cells: characterization and inhibition by glutamine antagonists.
    Molecular pharmacology, 1997, Volume: 51, Issue:5

    Topics: Azaserine; Diazooxonorleucine; Enzyme Inhibitors; gamma-Glutamyl Hydrolase; Glutamine; Humans; Isoxazoles; Kinetics; Methotrexate; Sarcoma; Substrate Specificity; Tumor Cells, Cultured

1997